Scholar Rock (SRRK) Stock Forecast, Price Target & Predictions
SRRK Stock Forecast
Scholar Rock stock forecast is as follows: an average price target of $40.50 (represents a -9.56% downside from SRRK’s last price of $44.78) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.
SRRK Price Target
SRRK Analyst Ratings
Buy
Scholar Rock Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Nov 13, 2024 | Etzer Darout | BMO Capital | $39.00 | $26.97 | 44.61% | -12.91% |
Oct 15, 2024 | Allison Bratzel | Piper Sandler | $42.00 | $28.52 | 47.27% | -6.21% |
Oct 11, 2024 | Etzer Darout | BMO Capital | $38.00 | $25.27 | 50.38% | -15.14% |
Jun 13, 2024 | Etzer Darout | BMO Capital | $31.00 | $9.39 | 230.14% | -30.77% |
May 23, 2024 | Allison Bratzel | Piper Sandler | $28.00 | $11.18 | 150.45% | -37.47% |
May 23, 2024 | Etzer Darout | BMO Capital | $29.00 | $11.18 | 159.39% | -35.24% |
Scholar Rock Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 3 | 6 |
Avg Price Target | - | $39.67 | $34.50 |
Last Closing Price | $44.78 | $44.78 | $44.78 |
Upside/Downside | -100.00% | -11.41% | -22.96% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Nov 13, 2024 | BMO Capital | Outperform | Outperform | Hold |
Oct 15, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Oct 11, 2024 | BMO Capital | Outperform | Outperform | Hold |
Oct 08, 2024 | Piper Sandler | Buy | Buy | Hold |
Sep 27, 2024 | Wedbush | Outperform | Outperform | Hold |
Aug 09, 2024 | BMO Capital | Outperform | Outperform | Hold |
Jun 13, 2024 | BMO Capital | Outperform | Outperform | Hold |
May 23, 2024 | Piper Sandler | Overweight | Overweight | Hold |
May 23, 2024 | BMO Capital | Outperform | Outperform | Hold |
Oct 24, 2023 | Jefferies | Buy | Upgrade | |
May 16, 2022 | Piper Sandler | Overweight | Overweight | Hold |
Scholar Rock Financial Forecast
Scholar Rock Revenue Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | $33.19M | - | $5.46M | $4.59M | $4.71M | $3.44M | $3.04M | $3.90M | $5.03M | $7.57M | $4.77M | $5.04M | $3.11M |
Avg Forecast | $7.60M | $2.02M | $8.07M | $2.11M | - | - | - | $22.13M | $4.40M | $4.64M | $5.20M | $6.00M | $6.51M | $7.63M | $6.85M | $24.81M | $5.19M | $9.11M | $5.28M | $4.77M |
High Forecast | $7.60M | $2.02M | $8.07M | $2.11M | - | - | - | $22.13M | $4.40M | $4.64M | $5.20M | $6.00M | $6.51M | $7.63M | $6.85M | $24.81M | $5.19M | $9.11M | $5.28M | $4.77M |
Low Forecast | $7.60M | $2.02M | $8.07M | $2.11M | - | - | - | $22.13M | $4.40M | $4.64M | $5.20M | $6.00M | $6.51M | $7.63M | $6.85M | $24.81M | $5.19M | $9.11M | $5.28M | $4.77M |
# Analysts | 1 | 1 | 1 | 1 | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Surprise % | - | - | - | - | - | - | - | 1.50% | - | 1.18% | 0.88% | 0.78% | 0.53% | 0.40% | 0.57% | 0.20% | 1.46% | 0.52% | 0.95% | 0.65% |
Forecast
Scholar Rock EBITDA Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
EBITDA | - | - | - | - | - | - | - | $-6.18M | $-34.64M | $-36.83M | $-30.07M | $-27.08M | $-26.25M | $-23.17M | $-18.89M | $-16.68M | $-11.19M | $-16.31M | $-11.96M | $-10.24M |
Avg Forecast | $-4.56M | $-1.21M | $-4.84M | $-1.27M | - | - | - | $-13.28M | $-2.64M | $-2.78M | $-3.12M | $-24.76M | $-3.91M | $-4.58M | $-4.11M | $-405.30M | $-3.12M | $-5.46M | $-3.17M | $-11.88M |
High Forecast | $-4.56M | $-1.21M | $-4.84M | $-1.27M | - | - | - | $-13.28M | $-2.64M | $-2.78M | $-3.12M | $-19.81M | $-3.91M | $-4.58M | $-4.11M | $-324.24M | $-3.12M | $-5.46M | $-3.17M | $-9.50M |
Low Forecast | $-4.56M | $-1.21M | $-4.84M | $-1.27M | - | - | - | $-13.28M | $-2.64M | $-2.78M | $-3.12M | $-29.71M | $-3.91M | $-4.58M | $-4.11M | $-486.36M | $-3.12M | $-5.46M | $-3.17M | $-14.25M |
Surprise % | - | - | - | - | - | - | - | 0.47% | 13.11% | 13.23% | 9.64% | 1.09% | 6.72% | 5.06% | 4.60% | 0.04% | 3.59% | 2.98% | 3.77% | 0.86% |
Forecast
Scholar Rock Net Income Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Net Income | - | - | - | - | - | - | - | $-8.97M | - | $-37.51M | $-30.71M | $-27.67M | $-26.57M | $-23.56M | $-19.28M | $-17.07M | $-11.57M | $-16.15M | $-12.53M | $-10.76M |
Avg Forecast | $-54.33M | $-62.57M | $-61.45M | $-61.05M | $-58.34M | $-56.30M | $-57.16M | $-55.18M | $-95.70M | $-79.00M | $-72.60M | $-25.30M | $-59.06M | $-51.07M | $-50.54M | $-414.80M | $-53.63M | $-29.77M | $-37.11M | $-12.48M |
High Forecast | $-54.33M | $-62.57M | $-61.45M | $-54.95M | $-51.53M | $-56.30M | $-57.16M | $-55.18M | $-95.70M | $-79.00M | $-72.60M | $-20.24M | $-59.06M | $-51.07M | $-50.54M | $-331.84M | $-53.63M | $-29.77M | $-37.11M | $-9.98M |
Low Forecast | $-54.33M | $-62.57M | $-61.45M | $-68.17M | $-65.14M | $-56.30M | $-57.16M | $-55.18M | $-95.70M | $-79.00M | $-72.60M | $-30.36M | $-59.06M | $-51.07M | $-50.54M | $-497.76M | $-53.63M | $-29.77M | $-37.11M | $-14.97M |
Surprise % | - | - | - | - | - | - | - | 0.16% | - | 0.47% | 0.42% | 1.09% | 0.45% | 0.46% | 0.38% | 0.04% | 0.22% | 0.54% | 0.34% | 0.86% |
Forecast
Scholar Rock SG&A Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
SG&A | - | - | - | - | - | - | - | $10.76M | $10.36M | $11.28M | $9.27M | $9.37M | $7.76M | $8.27M | $6.37M | $5.82M | $5.86M | $6.18M | $4.71M | $4.07M |
Avg Forecast | $11.07M | $2.95M | $11.76M | $3.08M | - | - | - | $32.25M | $6.42M | $6.76M | $7.58M | $8.75M | $9.49M | $11.12M | $9.98M | $36.16M | $7.57M | $13.27M | $7.70M | $4.72M |
High Forecast | $11.07M | $2.95M | $11.76M | $3.08M | - | - | - | $32.25M | $6.42M | $6.76M | $7.58M | $8.75M | $9.49M | $11.12M | $9.98M | $36.16M | $7.57M | $13.27M | $7.70M | $5.67M |
Low Forecast | $11.07M | $2.95M | $11.76M | $3.08M | - | - | - | $32.25M | $6.42M | $6.76M | $7.58M | $8.75M | $9.49M | $11.12M | $9.98M | $36.16M | $7.57M | $13.27M | $7.70M | $3.78M |
Surprise % | - | - | - | - | - | - | - | 0.33% | 1.61% | 1.67% | 1.22% | 1.07% | 0.82% | 0.74% | 0.64% | 0.16% | 0.77% | 0.47% | 0.61% | 0.86% |
Forecast
Scholar Rock EPS Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
EPS | - | - | - | - | - | - | - | $-0.24 | - | $-1.02 | $-0.84 | $-0.76 | $-0.89 | $-0.79 | $-0.65 | $-0.58 | $-0.39 | $-0.55 | $-0.48 | $-0.42 |
Avg Forecast | $-0.56 | $-0.64 | $-0.63 | $-0.63 | $-0.60 | $-0.58 | $-0.59 | $-0.57 | $-0.99 | $-0.82 | $-0.75 | $-0.68 | $-0.61 | $-0.53 | $-0.52 | $0.01 | $-0.55 | $-0.31 | $-0.38 | $-0.48 |
High Forecast | $-0.56 | $-0.64 | $-0.63 | $-0.57 | $-0.53 | $-0.58 | $-0.59 | $-0.57 | $-0.99 | $-0.82 | $-0.75 | $-0.68 | $-0.61 | $-0.53 | $-0.52 | $0.01 | $-0.55 | $-0.31 | $-0.38 | $-0.48 |
Low Forecast | $-0.56 | $-0.64 | $-0.63 | $-0.70 | $-0.67 | $-0.58 | $-0.59 | $-0.57 | $-0.99 | $-0.82 | $-0.75 | $-0.68 | $-0.61 | $-0.53 | $-0.52 | $0.01 | $-0.55 | $-0.31 | $-0.38 | $-0.48 |
Surprise % | - | - | - | - | - | - | - | 0.42% | - | 1.25% | 1.12% | 1.12% | 1.46% | 1.50% | 1.25% | -48.33% | 0.71% | 1.79% | 1.25% | 0.88% |
Forecast
Scholar Rock Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
PASG | Passage Bio | $0.67 | $6.00 | 795.52% | Buy |
BDTX | Black Diamond Therapeutics | $2.50 | $20.00 | 700.00% | Buy |
HOWL | Werewolf Therapeutics | $1.64 | $12.00 | 631.71% | Buy |
KROS | Keros Therapeutics | $18.00 | $102.00 | 466.67% | Buy |
RLAY | Relay Therapeutics | $4.50 | $18.00 | 300.00% | Buy |
ANAB | AnaptysBio | $15.99 | $49.83 | 211.63% | Buy |
ARVN | Arvinas | $19.10 | $58.50 | 206.28% | Buy |
CGEM | Cullinan Oncology | $11.49 | $34.00 | 195.91% | Buy |
IGMS | IGM Biosciences | $7.48 | $18.67 | 149.60% | Buy |
PLRX | Pliant Therapeutics | $14.37 | $35.50 | 147.04% | Buy |
MLYS | Mineralys Therapeutics | $12.35 | $30.00 | 142.91% | Buy |
STOK | Stoke Therapeutics | $12.10 | $26.50 | 119.01% | Buy |
IDYA | IDEAYA Biosciences | $26.33 | $53.33 | 102.54% | Buy |
RNA | Avidity Biosciences | $32.74 | $59.00 | 80.21% | Buy |
DSGN | Design Therapeutics | $6.25 | $9.67 | 54.72% | Buy |
RVMD | Revolution Medicines | $45.16 | $65.67 | 45.42% | Buy |
MGTX | MeiraGTx | $6.40 | $9.00 | 40.63% | Buy |
SRRK | Scholar Rock | $43.65 | $40.50 | -7.22% | Buy |
IKNA | Ikena Oncology | $1.62 | $1.33 | -17.90% | Buy |